Israeli Femtech Products to Keep an Eye On

With new products consistently added to a large base, Femtech is full of promise. This domain combines pioneering advancements in women’s health with cutting-edge technology to redefine the landscape of female-centric healthcare. 

What Women’s Health Issues Do Femtech Products Address?

Femtech encompasses four key pillars, each representing a critical facet of women’s health and well-being: 

• Fertility and Menstrual Health: An array of innovative solutions aids women in managing their reproductive cycles, offering tools for cycle tracking, ovulation prediction, and symptom management. 

• Pregnancy and Maternal Health: Technologies designed to support expectant mothers through every stage of their journey, from prenatal care to postpartum recovery. 

• Menopause and Perimenopause: Solutions providing relief and support to women navigating this transformative phase of life. 

• Reproductive Health and Wellness: Resources and tools to empower women to take charge of their reproductive health journey. 
• And more…

This sector is revolutionizing women’s health, laying the groundwork for a future where every woman can access personalized, comprehensive healthcare solutions tailored to her unique needs. 

Israel’s innovation ecosystem drives global advancements in women’s health with various companies and products. 

Femtech Devices 

Femtech devices that are reshaping the landscape of women’s health and wellness. Here are five leading devices developed by Israeli Femtech companies that are making a significant impact. 

1. Annabella Breast Pump

The Annabella Breast Pump is the first pump designed to simulate a baby’s tongue movement, aiming to stimulate milk production more naturally and efficiently. It features a soft silicone-covered breast shield and offers an adjustable size range to maximize comfort. By mimicking the wave-like motion of a baby’s tongue, the pump encourages the brain to produce more milk, offering a more pleasant pumping experience closer to natural breastfeeding.

Annabella Tech was founded in 2017 by Masha Waldberg. Masha, who struggled to breastfeed and pump, intimately understood her target market’s problem. With almost $8 million in funding, their product hit the market in Israel in February 2023 and has been capturing 5%—10 % of the market ever since. Now raising its seed round in funding, Annabella Tech looks to take its groundbreaking product to the US market and beyond.

Visit Annabella Tech’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

2. TrueLabor Maternal Fetal Monitor 

The TrueLabor™ Maternal Fetal Monitor from OB-Tools is a groundbreaking, noninvasive device revolutionizing labor and delivery monitoring. It provides maternal-fetal medicine specialists and OB-GYNs with the tools to accurately identify, measure, and evaluate uterine contractions and fetal heart rate. The system distinguishes between true and false labor signs, ensuring accurate, safe, and secure readings even in challenging conditions, thereby setting new standards in obstetric care. 

OB Tools, founded in 2003, is a mature company specializing in innovative maternal-fetal medicine and obstetrics solutions. The company focuses on developing noninvasive technologies to improve the accuracy and safety of labor and delivery monitoring, with its flagship product being the TrueLabor™ Maternal Fetal Monitor. As a well-established entity in the healthcare sector, OB Tools operates with a business model centered on providing advanced, reliable products to healthcare professionals, aiming to enhance obstetric care globally. 

Visit OB Tool’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

3. Fertissimo System for IVF Embryo Selection

The Fertissimo System, featuring the TCL Analyzer, is a state-of-the-art, non-invasive solution for optimal IVF embryo selection. By leveraging oxidative stress as a key biomarker of embryo viability, this system offers a novel approach to assessing embryos. The TCL Analyzer, a critical component of the Fertissimo System, enables the analysis of multiple embryos without disruption, completing each assessment swiftly in just eight minutes. This technology significantly enhances the IVF process, aiming to increase the chances of success.

Carmel Diagnostics, founded in 2009, is an innovative player in fertility diagnostics. The company has raised just under $7 million in its seed funding stage. Focused on enhancing IVF success rates through advanced technologies like the Fertissimo System, Carmel Diagnostics combines scientific research with practical application to support fertility journeys. Their approach to non-invasive embryo selection represents a significant advancement in reproductive technology.

Visit Carmel Diagnostic’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

4. The Hormone-Free IUB Ballerine

The IUB Ballerine is a hormone-free intrauterine device (IUD) designed by OCON Healthcare to provide a safe, next-generation contraceptive option that conforms to a woman’s anatomy. It represents a significant advancement in women’s health, offering a long-acting, reversible contraceptive method without the use of hormones, which can reduce the risk of side effects associated with hormonal contraceptives.

Founded in 2011, OCON Healthcare has been at the forefront of introducing innovative, hormone-free contraceptive solutions, raising $6.5 million in Series A funding to support its mission. Their product line, including the IUB Ballerine, IUB SEAD for managing abnormal uterine bleeding, and IUB PRIMA, showcases their commitment to providing safer, user-centered options in women’s healthcare. These products represent a significant leap forward in offering non-invasive, effective contraceptive and treatment options, emphasizing OCON’s dedication to advancing women’s health globally.

Visit OCON Therapeutics’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

5. The Illumigyn Gynescope® System

The Illumigyn Gynescope® System represents a breakthrough in gynecological care. It combines a cutting-edge optical device with advanced software for capturing and analyzing detailed gynecological images. This system facilitates a comprehensive examination process, enabling healthcare providers to obtain high-quality, magnified images for accurate diagnostics and treatment planning.

Illumigyn, founded in 2012 and currently in a Series A funding round with $38 million raised, is at the forefront of transforming gynecological healthcare. Their innovative Gynescope® System illustrates their dedication to enhancing diagnostic capabilities and improving outcomes in women’s health globally.

Visit Illumigyn’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

Femtech Apps & Software Products

Not to be left behind, Femtech apps and software also play a pivotal role, marking a new era of digital healthcare solutions tailored specifically for women. These platforms, leveraging the latest in AI, data analytics, and user-friendly interfaces, are revolutionizing how women manage their health, offering personalized insights and support across various stages of life.

Femtech apps and software are becoming essential for women in 2024, from breastfeeding tracking analysis to advancing IVF through AI. Below, we’ll highlight five innovations you should keep on your radar.

1. MyLee: Breastfeeding Tracking & Analysis Platform 

MyLee, by MyMilk Labs, is a groundbreaking device designed for breastfeeding mothers. It offers personalized insights into their breast milk’s nutritional content and production. This innovative tool enhances the breastfeeding experience by providing valuable feedback to improve breastfeeding practices. Available on the market, MyLee is a testament to MyMilk Labs’ commitment to supporting mothers in their breastfeeding journey.

Established in 2012, MyMilk Labs is in the midst of a pre-seed funding round, demonstrating its potential and commitment to revolutionizing maternal health. The company’s flagship product, MyLee, reflects its dedication to empowering breastfeeding mothers with actionable insights, facilitating a more informed and positive breastfeeding experience. With MyLee already making its mark on the market, MyMilk Labs is poised to contribute significantly to maternal and infant health.

Visit MyMilk Lab’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

2. INVU: Remote Fetal Non-Stress Testing Platform 

INVU by Nuvo offers a revolutionary approach to prenatal care with its remote fetal non-stress testing platform. This solution enables expectant mothers to monitor maternal and fetal heart rates from home. This solution represents a significant advancement in maternal healthcare, offering peace of mind and enhanced safety. It’s a testimony to the power of technology in transforming prenatal monitoring and care.

Nuvo was founded in 2007 and has made remarkable maternal and fetal health strides. Gaining FDA clearance in 2020 for its innovative monitoring technologies and partnering with Philips in 2022, Nuvo is at the forefront of prenatal healthcare innovation, providing solutions designed to improve outcomes for mothers and babies worldwide.

Visit Nuvo Group’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

3. EMA: AI Embryology Platform

EMA is an AI embryology platform created by AIVF. Using years of research combined with cutting-edge technology, AIVF leverages artificial intelligence to revolutionize the IVF process, giving embryologists advanced tools to analyze and select viable embryos. This platform represents a pivotal change in fertility treatments, aiming to increase success rates and support families on their journey to parenthood.

AIVF, established in 2018, is dedicated to enhancing fertility treatments through AI. With $25 million raised in Series A funding, AIVF is making significant contributions to reproductive medicine, demonstrating a strong commitment to improving the IVF experience for patients worldwide.

Visit AIVF’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

4. CHLOE: AI-Based IVF Decision Support  

CHLOE is at the forefront of integrating artificial intelligence into the in-vitro fertilization (IVF) journey, offering a decision-support platform that revolutionizes how fertility specialists approach treatment. By harnessing the power of AI to analyze vast amounts of data, CHLOE assists in making more informed decisions, potentially increasing the chances of successful pregnancies. This innovative tool is designed to bring clarity and precision to the IVF process, helping doctors and patients navigate the complex landscape of fertility treatments more confidently.

Fairtility, founded in 2019 and currently in a Series A funding round with $18.5 million raised, is pioneering in the field of fertility technology – including with the CHLOE product. Their focus on AI-driven solutions for IVF is setting new standards for success and efficiency in fertility treatments, offering hope and support to families worldwide.

Visit Fairtility’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

5. Expecting: AI-Based Surrogacy System 

Expecting is a product that tackles the many problems involved with surrogacy. It utilizes artificial intelligence to reimagine the surrogacy experience, offering a comprehensive system that streamlines surrogacy’s matching and management aspects. Its AI-driven approach simplifies the journey for intended parents and surrogates by optimizing compatibility and providing ongoing support. Expecting’s platform aims to make surrogacy more transparent, manageable, and accessible, reducing the stress and uncertainty that can often accompany such a significant life event.

Launched in 2020, Expecting uses AI to facilitate surrogacy processes. It is raising a seed round, with $1.5 million raised to date, as it continues innovating in the surrogacy sector. 

Visit Expecting’s Finder page for the most up-to-date information about this exciting Femtech company and its products.

The Future of Femtech Products

The femtech landscape in Israel is a vibrant blend of physical devices, apps, and software, each innovatively designed to cater to women’s health needs worldwide. This diverse array of solutions bridges gaps and addresses a wide spectrum of wellness areas.